Event Videos
https://pubmed.ncbi.nlm.nih.gov/39643582/ Cholestasis Review Hepatobiliary Pancreat Dis Int. 2024 Nov 16:S1499-3872(24)00160-7. Challenges for pediatric liver transplantation in mainland China: Where we are and where to go. Reflections from worldwide largest pediatric liver transplantation program Qiang Xia 1, Ming-Xuan Feng 2 Abstract Published on:
Nov-2024
|
https://pubmed.ncbi.nlm.nih.gov/39526564/ MASLD Review J Pediatr Gastroenterol Nutr. 2024 Nov 11. Pharmacological management of pediatric metabolic dysfunction-associated steatotic liver disease Rasha Abi Radi Abou Jaoudeh 1, Phillipp Hartmann 2 3, Ole Olson 4, Olga Gupta 5, Seema Kumar 6, Samar H Ibrahim 7, Rima Fawaz 8, Amal Aqul 9, Sara Hassan 7 Affiliations expand Abstract Published on:
Nov-2024
|
https://pubmed.ncbi.nlm.nih.gov/39604995/ Cholestasis BMC Pediatr. 2024 Nov 27;24(1):777. Analysis of the clinical characteristics of patients with Kawasaki disease complicated with cholestasis Pingping Yang 1, Lingzhe Meng 1, Jing Guo 2 Background: To explore the clinical characteristics, related factors, and prognosis of Kawasaki disease (KD) combined with acute febrile cholestasis and improve the understanding of the liver complications of KD to avoid misdiagnosis and missed diagnosis. Published on:
Nov-2024
|
https://pubmed.ncbi.nlm.nih.gov/39526563/ Biliary atresia J Pediatr Gastroenterol Nutr. 2024 Nov 11. The association of human milk intake and outcomes in biliary atresia Mary Elizabeth M Tessier 1, Jeremy M Schraw 2 3, Stacey Beer 1, Sanjiv Harpavat 1, M Kyle Jensen 4, John C Magee 5, Vicky Ng 6, Michael E Scheurer 2 3, Sarah A Taylor 7, Benjamin L Shneider 1 Objectives: Human milk intake has many benefits which could influence outcomes in biliary atresia (BA). However, the role of human milk in BA has not been examined. We hypothesized that human milk intake would be associated with improved outcomes in BA. Published on:
Nov-2024
|
https://pubmed.ncbi.nlm.nih.gov/39574069/ MASLD Meta-Analysis BMC Med. 2024 Nov 21;22(1):548. Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis Published on:
Nov-2024
|
https://pubmed.ncbi.nlm.nih.gov/39426991/ MASLD Sci Rep. 2024 Oct 19;14(1):24593. Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study Li-Ping Zhang # 1, Hua-Xing Wei # 2, Shi-Hui Lin 1, Bin-Wei Qiu 1, Jin-Liang Lin 1 PMCID: PMC11490505 DOI: 10.1038/s41598-024-75298-0 Abstract Published on:
Oct-2024
|
https://pubmed.ncbi.nlm.nih.gov/39560782/ MASLD Review Eur J Pediatr. 2024 Nov 19;184(1):29. Pediatric MASLD: current understanding and practical approach Published on:
Nov-2024
|
https://pubmed.ncbi.nlm.nih.gov/39434194/ MASLD BMC Nutr. 2024 Oct 21;10(1):140. The association of fructose and fiber consumption and physical activity with non-alcoholic fatty liver disease in children and adolescents: a cross-sectional study Camellia Akhgarjand 1, Mahdieh Entezarian 1, Simin Samavat 2, Aryan Tavakoli 1, Aliarash Anoushirvani 3 4, Golaleh Asghari 5, Emad Yusbashian 6, Pooneh Dehghan 7, Parvin Mirmiran 6, Hossein Imani 8 PMCID: PMC11494766 DOI: 10.1186/s40795-024-00943-w Published on:
Oct-2024
|
https://pubmed.ncbi.nlm.nih.gov/39552453/ cholangitis J Pediatr Gastroenterol Nutr. 2024 Nov 18. doi: 10.1002/jpn3.12414. Online ahead of print. Portal hypertension in doublecortin domain-containing protein 2 (DCDC2) related neonatal sclerosing cholangitis Prabhsaran Kaur 1, Bikrant Bihari Lal 1, Deepa Janakiraman 2, Nirmala Dheivamani 2, Snehavardhan Pandey 3, Ashish Bavdekar 4, Aashay Shah 5, Sanjeev Kumar Verma 6, Vaibhav Shah 7, Arjun Maria 8, Nishant Wadhwa 8, Sumit Kumar Singh 9, Vikrant Sood 1, Rajeev Khanna 1, Seema Alam 1 Abstract Published on:
Nov-2024
|
https://pubmed.ncbi.nlm.nih.gov/39438332/ NAFLD Eur J Pediatr. 2024 Dec;183(12):5489-5496. Increased inter-atrial and intra-atrial conduction times in pediatric patients with non-alcoholic fatty liver disease Doaa El Amrousy 1, Heba El Ashry 2, Sara Maher 3, Yousef Elsayed 4, Karim Elkashlan 5, Dina Abdelhai 6, Wegdan Mawlana 7, Samir Hasan 7 PMCID: PMC11527969 DOI: 10.1007/s00431-024-05809-8 Published on:
Oct-2024
|